BioCentury
ARTICLE | Clinical News

Truvada emtricitabine/tenofovir regulatory update

December 19, 2011 8:00 AM UTC

Gilead submitted an sNDA to FDA for Truvada emtricitabine/tenofovir for pre-exposure prophylaxis to reduce the risk of HIV-1 infection in uninfected adults. The fixed-dose combination of the nucleosid...